Defibrillation effects of intravenous nifekalant in patients with out-of-hospital ventricular fibrillation.

Igarashi, Masaki; Fujino, Tadashi; Toyoda, Miwako; Sugino, Keishi; Sasao, Kenichirou; Sasamoto, Shuichi; Otsuka, Takayuki; Kobayashi, Kenzaburo; Okano, Yoshifumi; Yosiwara, Katsunori; Koyama, Nobuya

Igarashi, Masaki; Fujino, Tadashi; Toyoda, Miwako; Sugino, Keishi; Sasao, Kenichirou; Sasamoto, Shuichi; Otsuka, Takayuki; Kobayashi, Kenzaburo; Okano, Yoshifumi; Yosiwara, Katsunori; Koyama, Nobuya.

Affiliation

Igarashi M; Critical Care Center, Toho Omori University Hospital, Otaku, Tokyo, Japan. masaki50@oak.ocn.ne.jp

Pacing Clin Electrophysiol ; 28 Suppl 1: S155-7, 2005 Jan.

Article in En | MEDLINE | ID: mdl-15683486

Subject(s)

Anti-Arrhythmia Agents/administration & dosage; Pyrimidinones/administration & dosage; Ventricular Fibrillation/drug therapy; Adult; Aged; Electric Countershock; Emergency Treatment; Female; Humans; Injections, Intravenous; Male; Middle Aged; Ventricular Fibrillation/therapy

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Pyrimidinones / Ventricular Fibrillation / Anti-Arrhythmia Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2005 Type: Article

Search on Google

XML

PubMed Links